A COMPARATIVE ASSESSMENT OF THE BIOCHEMICAL ANALYSIS OF THE COURSE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH COVID-19
Keywords:
COVID - 19, nonalcoholic fatty liver disease, biochemical analysis, total bilirubin, total cholesterol, atherogenic indexAbstract
This article analyzes a special experiment on the parameters of pigment metabolism, cytolysis and cholestasis to assess the functional state of the liver in non-alcoholic fatty liver disease in middle-aged and elderly patients who underwent COVID-19. The study included a control group of patients who did not have COVID-19, an experimental group of patients diagnosed with COVID-19, a history (periodic abstinence from alcoholic beverages) was collected to rule out alcoholic fatty liver disease and isolated using a special CAGE examination. The conclusion was made on the basis of the PCR test COVID-19.
References
IlchenkoL.Yu., Nikitin I.G., Fedorov I.G. COVID-19 and liver damage. Archive of internal medicine. 2020;10(3):188-197. https://doi.org/10.20514/2226-6704-2020-10-3-188-197
Maev I.V., Bordin D.S. Management of patients with chronic liver diseases in the context of the COVID-19 pandemic // Guidelines // Moscow 2020. - page 28.
Mannanova I. V., PonezhevaZh. B., Makashova V. V., OmarovaKh. G., Reizis A. R., Gorelov A. V. 2020. Some aspects of liver damage in sars-cov infection-2.COVID-19 preprints.microbe.ru.https://doi.org/10.21055/preprints-3111776
Pinchuk T. V., Orlova N. V., Suranova T. G., Bonkalo T. I. Mechanisms of liver damage in COVID 19. Medical alphabet. 2020; (19): 39–46. https://doi.org/10.33667/2078-5631-2020-19-39-46.
Reizis A. R., PonezhevaZh. B., Makashova V. V., OmarovaKh. G., Mannanova I. V., Gorelov A. V. 2020. Liver damage in COVID-19. Covid19-preprints.microbe.RU. https://doi.org/10.21055/preprints-3111760
Reizis A. R., PonezhevaZh. B., Makashova V. V., OmarovaKh. G., Mannanova I. V., Gorelov A. V. 2020. Chronic liver diseases during the COVID-19 pandemic. Russia .2020. – pp.-1-7.
Tukhbatullin M.G., Yangurazova A.E., Galeeva Z.M. Shear wave ultrasound elastography and laboratory parameters in the diagnosis and evaluation of the effectiveness of treatment of non-alcoholic fatty liver disease. Practical medicine. 1 (112) March 2018. P.-105-111.
Bangash M. N.; Patel J.; Parekh D. COVID-19 and the liver: Little cause for concern. Lancet Gastroenterol. Hepatol. 2020, 5, 529–530. DOI: 10.1016/S 2468–1253(20)30084–4.
Chau TN, Lee KC, Yao H, Tsang TY, Chow TC, et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. hepatology. 2004; 39:302–310. DOI: 10.1002/hep.20111.
Hamrayev A.A., Yuldasheva D.H. Clinical, laboratory and molecular-genetic markers of the progression of non-alcoholic fatty liver disease (literature review and own data) // Society and innovations // Special Issue –2 (2021). - P. 399 - 406.
Yuldasheva D.H., Zokirov V.Z., G`ulomovaSh.Q. Non-alcoholic fatty liver disease: Modern view of the problem // A Multidisciplinary Peer Reviewed Journal.Vol.6. Issue 12. Dec. 2020. – P. 286 – 292
Yuldasheva D.H. Shadjanova N.S., Oltiboev R.O. Non-alcoholic fatty liver disease and modern medicine // Academicia an international multidisciplinary research journal // Vol.10. Issue 11 Nov. 2020. – P. 1931 – 1937.
Yuldasheva D.H., Zokirov V.Z., Oltiboev R.O. Modern approaches to the pathogenesis of non-alcoholic fatty liver disease // Euro-Asia Conferences. - 2021. - P. 384-389.
Yuldasheva D.H., Muxamedova Z.R., Zokirov V.Z. Chronic liver disease and COVID-2019 // E-Conference Globe. - 2021. - P. 193-197.
Zokirov V.Z., Yuldasheva D.H., Muxamedova Z.R., Nasirova Z.J. Assessment of comparative analysis of the course of non-alcoholic fatty liver disease in middle-aged and elderly patients who suffer covid-19 through ultrasound elastometry (via fibroscan). // World Bulletin of Public Health (WBPH) Available Online. Vol.5. December-2021 – P. 64 – 66
Yuldasheva D.X., Hamrayev A.A. Prevalence of non-alcoholic fatty liver disease, clinical and laboratory markers// Central Asian Journal of Medicine Volume 2022 Issue 2 – P. 112-123
Zokirov V.Z. (2021). ChRONIC LIVER DISEASE AND COVID-2019 (LITERATURE REVIEW AND OWN DATA) // RESEARCh JOURNAL OF TRAUMA AND DISABILITY STUDIES. Vol.1. December-2021 – P. 1–6
Zokirov V.Z. (2021). Assessment Of Comparative Analysis Of The Course Of Non-Alcoholic Fatty Liver Disease In Middle-Aged And Elderly Patients Who Suffer Covid-19 Through Ultrasound Elastometry (Via Fibroscan). JOURNAL OF INTELLECTUAL PROPERTY AND HUMAN RIGHTS, 1(6), Vol.5. December-2021 – P.18–22.
Zokirov V.Z. (2022). COVID 19 O‘TKAZGAN VA O‘TKAZMAGAN JIGARNING NOALKAGOL YoG‘XASTALIGI BILAN OG‘RIGAN BEMORLAR KLINIKASI VA LABARATOR TAHLILLARINING SOLIShTIRMA TAHLILI. Scientific Progress Markazi, Yanvar 2022 – P. 670-675.
This research platform of the Integration of science, education and practice. Scientific-methodical journal in cooperation with the local and international agencies of the sector.